v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
CURRENT ASSETS:    
Cash and cash equivalents $ 19,749 $ 16,232
Receivables 12
R&D tax credit incentive receivable 685 654
Prepaid expenses and other current assets 1,102 1,012
Total current assets 21,548 17,898
Property and equipment, net 2,752 2,879
Operating lease right-of-use assets, net 16,616 17,230
Restricted cash 1,338 1,338
Deposits and other assets 99 48
TOTAL ASSETS 42,353 39,393
CURRENT LIABILITIES:    
Accounts payable 1,465 1,032
Accrued expenses 1,504 1,736
Litigation accrual 1,675 1,675
Accrued compensation expense 349 365
Lease liability, current portion 1,782 1,794
Total current liabilities 6,775 6,602
Lease liability, noncurrent portion 16,493 17,061
TOTAL LIABILITIES 23,268 23,663
Commitments and contingencies (Note 12)
Stockholders’ equity:    
Common stock, par value $0.0001 per share; 300,000 shares authorized; shares issued and outstanding: 84,648 and 76,428 at March 31, 2026 and December 31, 2025, respectively 8 8
Additional paid-in capital 174,358 164,225
Accumulated other comprehensive income 32 30
Accumulated deficit (155,313) (148,533)
TOTAL STOCKHOLDERS' EQUITY 19,085 15,730
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 42,353 $ 39,393